p38 differentially regulates ERK, p21, and mitogenic signalling in two pancreatic carcinoma cell lines

[1]  W. Bonner,et al.  p21: A Two-Faced Genome Guardian. , 2017, Trends in molecular medicine.

[2]  G. H. Thoresen,et al.  HGF-induced DNA synthesis in hepatocytes is suppressed by p38 , 2016, Growth factors.

[3]  L. Wood,et al.  Pancreatic cancer , 2016, The Lancet.

[4]  J. Ødegård,et al.  Lysophosphatidic acid induces both EGFR-dependent and EGFR-independent effects on DNA synthesis and migration in pancreatic and colorectal carcinoma cells , 2016, Tumor Biology.

[5]  A. Biankin,et al.  Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer , 2016, British Journal of Cancer.

[6]  R. DePinho,et al.  Genetics and biology of pancreatic ductal adenocarcinoma. , 2006, Genes & development.

[7]  L. Cope,et al.  Functional p38 MAPK Identified by Biomarker Profiling of Pancreatic Cancer Restrains Growth through JNK Inhibition and Correlates with Improved Survival , 2014, Clinical Cancer Research.

[8]  R. Xiang,et al.  Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence. , 2014, Trends in biochemical sciences.

[9]  J. Ødegård,et al.  The involvement of the docking protein Gab1 in mitogenic signalling induced by EGF and HGF in rat hepatocytes. , 2013, Biochimica et biophysica acta.

[10]  T. Christoffersen,et al.  Migration induced by epidermal and hepatocyte growth factors in oral squamous carcinoma cells in vitro: role of MEK/ERK, p38 and PI-3 kinase/Akt. , 2012, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[11]  A. Cuadrado,et al.  Mechanisms and functions of p38 MAPK signalling. , 2010, The Biochemical journal.

[12]  Xinbin Chen,et al.  Examination of the expanding pathways for the regulation of p21 expression and activity. , 2010, Cellular signalling.

[13]  J. Shea,et al.  Phenotype and Genotype of Pancreatic Cancer Cell Lines , 2010, Pancreas.

[14]  S. Sen,et al.  Genetic Variants of p21 and p27 and Pancreatic Cancer Risk in Non-Hispanic Whites: A Case-Control Study , 2010, Pancreas.

[15]  E. Wagner,et al.  Signal integration by JNK and p38 MAPK pathways in cancer development , 2009, Nature Reviews Cancer.

[16]  Anindya Dutta,et al.  p21 in cancer: intricate networks and multiple activities , 2009, Nature Reviews Cancer.

[17]  M. Rincón,et al.  Non-Classical P38 Map Kinase Functions: Cell Cycle Checkpoints and Survival , 2008, International journal of biological sciences.

[18]  S. F. Konieczny,et al.  Mist1 regulates pancreatic acinar cell proliferation through p21 CIP1/WAF1. , 2008, Gastroenterology.

[19]  Z. Dvořák,et al.  SB203580, a pharmacological inhibitor of p38 MAP kinase transduction pathway activates ERK and JNK MAP kinases in primary cultures of human hepatocytes. , 2008, European journal of pharmacology.

[20]  Toshiaki Tanaka,et al.  Up‐regulation of p21CIP1 expression mediated by ERK‐dependent and ‐independent pathways contributes to hepatocyte growth factor‐induced inhibition of HepG2 hepatoma cell proliferation , 2008, Journal of cellular biochemistry.

[21]  Jukka Westermarck,et al.  Phosphatase‐mediated crosstalk between MAPK signaling pathways in the regulation of cell survival , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  P. Cohen,et al.  The selectivity of protein kinase inhibitors: a further update. , 2007, The Biochemical journal.

[23]  J. Pouysségur,et al.  ERK implication in cell cycle regulation. , 2007, Biochimica et biophysica acta.

[24]  P. Crowell,et al.  Cell Cycle Arrest by the Isoprenoids Perillyl Alcohol, Geraniol, and Farnesol Is Mediated by p21Cip1 and p27Kip1 in Human Pancreatic Adenocarcinoma Cells , 2007, Journal of Pharmacology and Experimental Therapeutics.

[25]  A. Scarpa,et al.  Increased stability of P21(WAF1/CIP1) mRNA is required for ROS/ERK-dependent pancreatic adenocarcinoma cell growth inhibition by pyrrolidine dithiocarbamate. , 2006, Biochimica et biophysica acta.

[26]  P. Gierschik,et al.  Oncogenic K-Ras down-regulates Rac1 and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38. , 2006, Cellular signalling.

[27]  J. Blenis,et al.  MAPK signal specificity: the right place at the right time. , 2006, Trends in biochemical sciences.

[28]  F. Bethencourt,et al.  The p38 transduction pathway in prostatic neoplasia , 2006, The Journal of pathology.

[29]  Yibin Wang,et al.  p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. , 2005, Genes & development.

[30]  Y. Xiong,et al.  Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues , 2005, Oncogene.

[31]  W. Fang,et al.  ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion. , 2004, Cancer letters.

[32]  P. Hofmann,et al.  Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytes. , 2004, American journal of physiology. Heart and circulatory physiology.

[33]  F. Beier,et al.  p38 MAP kinase signaling is necessary for rat chondrosarcoma cell proliferation , 2004, Oncogene.

[34]  Eun-Jung Lee,et al.  p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. , 2003, Cancer research.

[35]  T. Christoffersen,et al.  Role of ERK, p38 and PI3-kinase in EGF Receptor-Mediated Mitogenic Signalling in Cultured Rat Hepatocytes: Requirement for Sustained ERK Activation , 2003, Cellular Physiology and Biochemistry.

[36]  M. Korc,et al.  Multiple mitogenic pathways in pancreatic cancer cells are blocked by a truncated epidermal growth factor receptor. , 2002, Cancer research.

[37]  E. Friedman,et al.  The Stress-activated Protein Kinases p38α and JNK1 Stabilize p21Cip1 by Phosphorylation* , 2002, The Journal of Biological Chemistry.

[38]  R. Neve,et al.  Distinct roles for phosphoinositide 3-kinase, mitogen-activated protein kinase and p38 MAPK in mediating cell cycle progression of breast cancer cells , 2002, Oncogene.

[39]  G. Merlino,et al.  Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1 , 2002, Oncogene.

[40]  C. Ambrosino,et al.  Cell cycle regulation by p38 MAP kinases , 2001, Biology of the cell.

[41]  P. Humphrey,et al.  High-intensity p38 kinase activity is critical for p21(cip1) induction and the antiproliferative function of G(i) protein-coupled receptors. , 2001, Molecular pharmacology.

[42]  X. Ding,et al.  MEK/ERK-mediated proliferation is negatively regulated by P38 map kinase in the human pancreatic cancer cell line, PANC-1. , 2001, Biochemical and biophysical research communications.

[43]  A. Porras,et al.  p38 MAP kinases: beyond the stress response. , 2000, Trends in biochemical sciences.

[44]  F. Beier,et al.  The Raf-1/MEK/ERK Pathway Regulates the Expression of the p21Cip1/Waf1 Gene in Chondrocytes* , 1999, The Journal of Biological Chemistry.

[45]  R. Makino,et al.  Hepatocyte growth factor stimulates cell growth and enhances the expression of transforming growth factor α mRNA in AsPC-1 human pancreatic cancer cells , 1999, Journal of Gastroenterology.

[46]  G. Kapoor,et al.  One-way cross-talk between p38(MAPK) and p42/44(MAPK). Inhibition of p38(MAPK) induces low density lipoprotein receptor expression through activation of the p42/44(MAPK) cascade. , 1999, The Journal of biological chemistry.

[47]  C. Marshall,et al.  Cooperation of p38 and Extracellular Signal-regulated Kinase Mitogen-activated Protein Kinase Pathways during Granulocyte Colony-stimulating Factor-induced Hemopoietic Cell Proliferation* , 1999, The Journal of Biological Chemistry.

[48]  J. Pouysségur,et al.  Cyclin D1 Expression Is Regulated Positively by the p42/p44MAPK and Negatively by the p38/HOGMAPK Pathway* , 1996, The Journal of Biological Chemistry.

[49]  A. Bridges,et al.  A synthetic inhibitor of the mitogen-activated protein kinase cascade. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[50]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[51]  D. Stolz,et al.  Comparative effects of hepatocyte growth factor and epidermal growth factor on motility, morphology, mitogenesis, and signal transduction of primary rat hepatocytes , 1994, Journal of cellular biochemistry.

[52]  M. Refsnes,et al.  Stimulation of hepatocyte DNA synthesis by prostaglandin E2 and prostaglandin F2α additivity with the effect of norepinephrine, and synergism with epidermal growth factor , 1994, Journal of cellular physiology.

[53]  H. Tsubouchi,et al.  Biological and immunological properties of human hepatocyte growth factor from plasma of patients with fulminant hepatic failure. , 1990, Biochimica et biophysica acta.

[54]  E. Wagner,et al.  p38alpha: a suppressor of cell proliferation and tumorigenesis. , 2007, Cell cycle.

[55]  A. Nebreda,et al.  Regulation of Tumorigenesis by p38 α MAP Kinase , 2007 .

[56]  A. Fornace,et al.  p38 MAP kinase's emerging role as a tumor suppressor. , 2004, Advances in cancer research.

[57]  E. Friedman,et al.  The stress-activated protein kinases p38 alpha and JNK1 stabilize p21(Cip1) by phosphorylation. , 2002, The Journal of biological chemistry.

[58]  Jiahuai Han,et al.  The p38 signal transduction pathway: activation and function. , 2000, Cellular signalling.

[59]  R. Makino,et al.  Hepatocyte growth factor stimulates cell growth and enhances the expression of transforming growth factor alpha mRNA in AsPC-1 human pancreatic cancer cells. , 1999, Journal of gastroenterology.